Evidence map›Paper›PMID 28507601›Full record

ArticleTherapeutic advances in gastroenterology2017

End of treatment RNA-positive/sustained viral response in an individual with acute hepatitis C virus infection treated with direct-acting antivirals.

Eyal Shteyer, Harel Dahari, Ina Gafanovich, Ilana Dery, Dana Wolf, Scott J Cotler, Yoav Lurie

Open access · bronzeAbstract read
In one paragraph

Article in Therapeutic advances in gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2019
    Article
  2. Article
  3. Article
  4. A Robust and Efficient Numerical Method for RNA-Mediated Viral Dynamics.Frontiers in applied mathematics and statistics · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Eyal ShteyerPediatric Liver Unit, Shaare Zedek Medical Center, 12 Beit, Jerusalem, 91031, Israel.
Harel DahariThe Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Medical Center, Maywood, IL, USA.
Ina GafanovichLiver Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
Ilana DeryLiver Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
Dana WolfClinical Virology Unit, Department of Clinical Microbiology & Infectious Diseases, Hadassah University Hospital, Jerusalem, Israel.
Scott J CotlerThe Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Loyola University Medical Center, Maywood, IL, USA.
Yoav LurieLiver Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
Shaare Zedek Medical Center · ILLoyola University Medical Center · US

Funding

Collaborative Integration of HCV Molecular Virology and Mathematical ModelingR01AI078881 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PERELSON, ALAN S, UPRICHARD, SUSAN L. · 2011 to 2025
$7.5M
NIAID NIH HHS R01 AI078881
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28507601
PMCPMC5415096
OpenAlexW2592290539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.